BE773484A - Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs - Google Patents

Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs

Info

Publication number
BE773484A
BE773484A BE773484A BE773484A BE773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A
Authority
BE
Belgium
Prior art keywords
arylpyrimidines
bronchodilators
agglutination
inhibitors
preparing
Prior art date
Application number
BE773484A
Other languages
English (en)
French (fr)
Inventor
G G De Angelis
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE773484A publication Critical patent/BE773484A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE773484A 1970-10-05 1971-10-05 Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs BE773484A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (1)

Publication Number Publication Date
BE773484A true BE773484A (fr) 1972-04-05

Family

ID=22142671

Family Applications (1)

Application Number Title Priority Date Filing Date
BE773484A BE773484A (fr) 1970-10-05 1971-10-05 Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs

Country Status (16)

Country Link
US (1) US3707560A (fi)
JP (2) JPS5648511B1 (fi)
AT (4) AT316563B (fi)
AU (1) AU465734B2 (fi)
BE (1) BE773484A (fi)
CA (1) CA988519A (fi)
CH (4) CH542218A (fi)
DE (2) DE2149249C3 (fi)
DK (1) DK131858C (fi)
ES (4) ES395676A1 (fi)
FI (1) FI55502C (fi)
FR (1) FR2110227B1 (fi)
GB (2) GB1373536A (fi)
NL (1) NL168511C (fi)
SE (2) SE390304B (fi)
ZA (1) ZA716615B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 4―ヒドロキシピリミジン類の製造方法
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
CA2379064A1 (en) * 1999-07-15 2001-01-25 Pharmacopeia, Inc. Bradykinin b1 receptor antagonists
ES2290436T3 (es) * 2002-03-15 2008-02-16 Ciba Specialty Chemicals Holding Inc. Uso de 4-aminopiridinas para el tratamiento antimicrobiano de superficies.
ATE493987T1 (de) * 2002-05-22 2011-01-15 Amgen Inc Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
JP2006521345A (ja) * 2003-03-28 2006-09-21 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ニコチン性アセチルコリン受容体の正のアロステリック調節剤
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
EP2528441A4 (en) * 2010-01-25 2013-07-10 Chdi Foundation Inc CERTAIN KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
BR112014004845A2 (pt) 2011-08-30 2017-04-04 Chdi Foundation Inc pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
CA2844128C (en) 2011-08-30 2020-09-01 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
KR20170026633A (ko) 2014-07-17 2017-03-08 씨에이치디아이 파운데이션, 인코포레이티드 Hiv-관련 장애의 치료 방법 및 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
FR2110227A1 (fi) 1972-06-02
CH554346A (fr) 1974-09-30
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
GB1373536A (en) 1974-11-13
SE390304B (sv) 1976-12-13
NL168511B (nl) 1981-11-16
CH554876A (fr) 1974-10-15
CH554875A (fr) 1974-10-15
DE2149249C3 (de) 1975-07-03
ES420209A1 (es) 1976-06-01
AU465734B2 (en) 1975-10-09
DE2165962C2 (de) 1982-05-13
NL7113670A (fi) 1972-04-07
AT314540B (de) 1974-04-10
DE2165962A1 (de) 1972-08-31
DK131858C (da) 1976-02-16
JPS5648511B1 (fi) 1981-11-16
AT316563B (de) 1974-06-15
SE385885B (sv) 1976-07-26
AU3425971A (en) 1973-04-12
DE2149249B2 (de) 1974-11-07
US3707560A (en) 1972-12-26
DK131858B (da) 1975-09-15
NL168511C (nl) 1982-04-16
FI55502C (fi) 1979-08-10
GB1373535A (en) 1974-11-13
ES395676A1 (es) 1974-10-16
ES420211A1 (es) 1976-03-16
ZA716615B (en) 1972-06-28
CH542218A (fr) 1973-11-15
JPS578107B2 (fi) 1982-02-15
DE2149249A1 (de) 1972-04-13
AT315856B (de) 1974-05-15
FR2110227B1 (fi) 1975-02-07
FI55502B (fi) 1979-04-30
JPS5636468A (en) 1981-04-09
SE7410488L (fi) 1974-08-16
ES420210A1 (es) 1976-06-01

Similar Documents

Publication Publication Date Title
BE773484A (fr) Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs
RO62435A (fr) Procede pour la preparation des 1,2,4-triazolenucleosides
RO67478A (ro) Procedeu pentru prepararea unor pleuromutiline
RO64454A (fr) Procede pour la preparation des phenylimidazolyle-alkylalcanyles derives
RO62694A (fr) Procede pour la preparation des 3-methylencephalosporines
RO62442A (fr) Procede pour la preparation des aminophenylamidines
RO70438A (ro) Procedeu pentru prepararea unor pirol-2-carboxamide substituite
RO61063A (fr) Procede pour la preparation des naphtyle alkylamines
RO63012A (fr) Procede pour la preparation des n-(furrylmethyle)-morphinanes
BE780082A (fr) Composes nouveaux de traitement et de prevention de la coccidiose, et procede pour les preparer
RO64269A (fr) Procede pour la preparation des izoxazole-(5,4-d)-pirymidines
BE766734A (fr) Procede pour la preparation d'amines
RO68379A (ro) Procedeu pentru prepararea unor n-benzhidril-n'-p-hidroxibenzil-piperazine
RO62267A (fr) Procede pour la preparation des 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes
RO62296A (fr) Procede pour la preparation des phenylaminoalcanes
BE764203A (fr) Procede pour la preparation d'indenophtalazines
RO63671A (fr) Procede pour la preparation des cycloalcanomes et des cycloalcanoles
RO61927A2 (ro) Procedeu pentru prepararea unor tribrompirazolilacetamide
BE763637A (fr) Procede pour la preparation de thiourees symetriques 1,3- disubstitueesaliphatiques et cycloaliphatiques
BE750264A (fr) Procede pour la preparation d'amino-cetones
CH549557A (fr) Procede pour la preparation des thioethers de la cysteine.
RO63003A (fr) Procede pour la preparation des n-(heteroarylmethyl)-deltaen hauf-desoxynomorphines et des norcodeines
RO62760A (fr) Procede pour la preparation des 1-(4-aryle1-4-aryle2-buthyle)-pyperidines-4-substituees
RO63938A (fr) Procede pour la preparation des anilides
BE774307A (fr) Procede pour la preparation d'alcenylnorbornenes

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19841005